Description:

Avatan is a sterile eye drops containing Travoprost 0.004%. Travoprost, a prostaglandin analogue, is effective to reduce elevated intraocular pressure (IOP).

Composition:

Each ml contains Travoprost 0.04 mg. 

Indications:
Avatan Eye Drops is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of or insufficiently responsive to another intraocular pressure lowering medication, as monotherapy or as adjunctive therapy.

Dosage & Administration:

The recommended dose is one drops of Avatan in the conjunctival sac of the affected eye (s) once daily in the evening. If more than one topical ophthalmic product is being used, the medicines must be administered at least 5 minutes apart. When substituting another ophthalmic antiglaucoma agent with Avatan, discontinue the other agent and start the following day with Avatan.

Side-Effects:
The most frequently reported treatment-related side-effect was ocular hyperaemia. Approximately 3% of patients discontinued treatment due to conjunctival hyperaemia.

Contraindications:

Travoprost eye drops is contraindicated in patients with hypersensitive to travoprost or any excipients of this preparation.

Precautions:

Travoprost should be used with caution in patients with active intraocular inflammation (iritis/uveitis). Travoprost has not been studied in patients with renal or hepatic impairment and should be used with caution in such patients. Travoprost should not be administered while wearing contact lenses. . Contact lenses should be removed prior to the administration of the solution. Lenses may be reinserted 15 minutes following administration of Travoprost.

Warning:

Travoprost may cause changes to pigmented tissues.

Use in children and adolescents:

The efficacy and safety of Travoprost eye drops in patients below the age of 18 have not been established.

Use in pregnant women:

Trovoprost must not be used for pregnant women.

Use in lactating women:

Since animal studies indicate that travoprost and its metabolites may pass into breast milk, it must therefore not be used in breast-feeding women.

Storage:  

• Store below 25°C temperature. Don’t use the solution more than 30 days after opening.

• Keep out of reach of children.

Packing:

Each plastic dropper bottle containing 3 ml.